Search clinical trials for: Coartem®, Novartis

Total 14960 results

University of Oxford

Completed

Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day (AL3vs5)

Plasmodium Falciparum Infection

Myanmar
Leiden University Medical Center
Erasmus Medical Center

Completed

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza (RICH-3)

HIV

Netherlands
Epicentre
Medecins Sans Frontieres, Spain

Completed

Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria

Malaria, Falciparum

Congo, The Democratic Republic of the
UPECLIN HC FM Botucatu Unesp
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.

HIV Infections | Hypertriglyceridemia
Centers for Disease Control and Prevention

Completed

Non-malarial Febrile Illness in Children in Areas of Perennial Malaria Transmission

Malaria | Non-malarial Febrile Illness

Tanzania
University of Oxford

Completed

Investigating Meningococcal Vaccines in Adults

Meningococcal Infections | Neisseria Meningitidis | Meningococcal Vaccines | Factor H-binding Protein, Neisseria Meningitidi

United Kingdom
Papua New Guinea Institute of Medical Research
National Department of Health, Papua New Guinea; Australian Agency for International...

Completed

Artemether-Lumefantrine Clinical Effectiveness Study

Parasitologically Confirmed; Malarial

Papua New Guinea
Epicentre
University of Cape Town; Malaria Research and Training Center, Bamako, Mali

Completed

Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children (MAL-NUT)

Malaria | Severe Acute Malnutrition

Mali, Niger
Ain Shams Maternity Hospital

Unknown

Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery

Postpartum Hemorrhage

Egypt
Northern Orthopaedic Division, Denmark

Completed

Bone Remodeling Around HA-coated Acetabular Cups.

Coxarthrosis

Denmark
Medical University of Vienna

Withdrawn

Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease

Dry Eye Syndrome

Austria
IRCCS Multimedica

Completed

Removable Walker for Neuropathic Ulcers

Diabetic Foot

Italy
Centers for Disease Control and Prevention

Completed

Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children

P. Falciparum Malaria

Tanzania
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions

Influenza, Human

Germany
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Influenza | Influenza, Human | Influenza A Virus, H5N1 Subtype | Flu, Human | Flu, Avian

Australia, Germany, Italy
San Diego Radiosurgery

Unknown

Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer

Prostate Cancer

United States
Epicentre
Centre de Recherche Médicale et Sanitaire (Cermes), Niamey

Completed

Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger

Malaria

Niger
Boston University
Innovations for Poverty Action

Completed

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Cardiovascular Disease | Breast Cancer | Asthma | Diabetes Type II
University Hospital, Bonn

Completed

Oxytocin and the Processing of Social Stress-Associated Chemosignals

Healthy Volunteers
C. R. Bard

Terminated

Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM) (CONFIRM)

Popliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery Stenosis

United States
NHS Lothian
University of Edinburgh

Recruiting

Nexus Evaluation Primary Trident II Uncemented Shell (NEPTUNE)

Hip Dysplasia | Hip Osteoarthritis | Hip Arthropathy | Arthritis of Hip

United Kingdom
Cinnagen

Completed

Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma

Allergic Asthma | Uncontrolled Moderate to Severe

Iran, Islamic Republic of
University of Oxford

Completed

Understanding the Immune Response to Two Different Meningitis Vaccines

Meningitis | Meningococcal Disease | Septicaemia

United Kingdom
Diurnal Limited
Simbec Research; Brush Clinical Research Ltd.; Voet Consulting; Bionical Emas Ltd. and other collaborators

Completed

A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects

Adrenal Insufficiency

United Kingdom
Novartis
World Health Organization; Avenue Appia 20; CH - 1211 Geneva 27; Switzerland

Completed

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Plasmodium Falciparum Malaria

Kenya, Nigeria, Tanzania
Diurnal Limited
Simbec Research; Brush Clinical Research Ltd.; Voet Consulting; Medical Matters... and other collaborators

Completed

A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

Adrenal Insufficiency

United Kingdom
B. Braun Melsungen AG
Ernst von Bergmann Hospital

Completed

Post Market Surveillance of SeQuent Please Neo With Scoring Balloon (PASSWORD)

Coronary Artery Disease (CAD)

Germany
China Medical University Hospital

Completed

Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients

Beta-thalassemia Major
Tel-Aviv Sourasky Medical Center
Medical Corps, Israel Defense Force

Completed

A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers (RIVA-1)

Rivastigmine Toxicity

Israel
Novartis Vaccines

Completed

A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea

Meningococcal Disease | Meningococcal Meningitis

Korea, Republic of
University Hospital, Geneva

Completed

Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients

HIV Infection | Cancer | Transplant | Pediatrics | Rheumatic Disease

Switzerland
GlaxoSmithKline

Completed

Bioequivalence Study for Terbinafine 250 mg

Mycoses
Novartis Vaccines

Withdrawn

Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older

Meningococcal Disease
Novartis Vaccines
Novartis

Completed

A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY

Meningococcal Disease | Meningococcal Meningitis

United States
Inge Marie Svane

Withdrawn

Dendritic Cell Based Therapy for Breast Cancer Patients

Breast Cancer

Denmark
Universitätsklinikum Hamburg-Eppendorf

Unknown

Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis (FINGORHYMS)

Multiple Sclerosis

Germany
GlaxoSmithKline

Completed

Topiramate Bioequivalence Study Brazil - Fast

Epilepsy, Tonic-Clonic

Brazil
MicroPort Orthopedics Inc.

Terminated

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems

Joint Disease

Belgium
B. Braun Medical Industries Sdn. Bhd.
Seoul National University Hospital; Ulsan University Hospital; European Cardiovascular... and other collaborators

Recruiting

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease (REVERSE)

Myocardial Ischemia | Coronary Artery Disease | Acute Coronary Syndrome | Coronary Stenosis | De Novo Stenosis

Malaysia, Taiwan, Korea, Republic of, Singapore
University of Ibadan
Shin Poong Pharm Co Ltd 161 yoksam-ro, Gangnam-Gu Seoul 135-925, Korea; Institute...

Completed

Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine

Plasmodium Falciparum Malaria | Uncomplicated Malaria | Malaria Fever

Nigeria
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients

Malaria

Congo, The Democratic Republic of the, Gambia, Ghana, Indonesia, Kenya, Mali, Mozambique, Philippines, Senegal
University of Rochester

Completed

Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases

Neoplasm Metastasis

United States
Johns Hopkins Bloomberg School of Public Health
Tropical Diseases Research Centre

Active, not recruiting

Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials

Uncomplicated Falciparum Malaria

Zambia
Federico II University

Completed

Prediction of Tumor Shrinkage in Acromegaly

Acromegaly

Italy
Massachusetts General Hospital

Completed

Effect of Intranasal Oxytocin on Appetite and Caloric Intake in Men and Women

Eating Behavior

United States
University of Wisconsin, Madison

Withdrawn

A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus

New Onset Type 1 Diabetes Mellitus

United States
Groupe Francophone des Myelodysplasies
EpiCept Corporation

Withdrawn

Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

France
AO GENERIUM

Completed

Study of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair® (NAP)

Healthy Volunteers

Russian Federation
University of California, San Francisco

Withdrawn

Triadic Interactions of Families With Autism and Oxytocin (TAO)

Autism Disorder

United States
B. Braun Melsungen AG

Recruiting

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) (SCORE)

Coronary Artery Disease | Myocardial Ischaemia

Germany

Search clinical trials for: Coartem®, Novartis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations